9147 Bevacizumab and erlotinib as first-line therapy in advanced (stage IIIB/IV) non-squamous non-small-cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression – a multicenter phase II trial of SAKK

Saved in:
Bibliographic Details
Published inEuropean journal of cancer supplements Vol. 7; no. 2; p. 549
Main Authors Zappa, F, Droege, C, Betticher, D, von Moos, R, Ochsenbein, A, Stahel, R, Rauch, D, Schmid, P, Mayer, M, Pless, M
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 2009
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(09)71860-9